Transforming rural healthcare! Dr. Teresa Owens Tyson leads the Health Wagon, bringing vital diagnostic access, mobile ...

The median time to treatment initiation is increasing across cancer types, and this appears to be driven by an increase in stage I cancer diagnoses, data suggest.

In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.

CG Oncology, Inc.'s promising bladder cancer therapy, strong financials, and unique therapeutic profile make it a compelling ...

The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

HSHS St. John's Hospital is pioneering a new procedure using blue light technology to enhance the detection of bladder cancer ...

Given a surge in cancers such as prostate, bladder, kidney, and testicular, experts urge men to take the symptoms seriously ...

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

A breakthrough in bladder cancer treatment at the University of California, Davis: multifunctional nanoparticles enhance ...

Scientists at UC San Francisco have found a way to identify and possibly treat a mysterious type of bladder cancer that affects up to 1 in 4 cases.

“Pelvic floor therapy is like physical therapy to strengthen all the muscles and tissues in your pelvis that can become weak ...

Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies. Scientists at UC San Francisco have found a way to identify and possibly treat ...